Clinicopathological utility of molecular staging for melanoma patients undergoing sentinel lymphadenectomy.

Hiroya Takeuchi; Bret Taback; Christine Kuo; Dave S. B. Hoon

doi:10.1007/BF02523620

Clinicopathological utility of molecular staging for melanoma patients undergoing sentinel lymphadenectomy.

Hiroya Takeuchi
, Bret Taback
, Christine Kuo
, Dave S. B. Hoon

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Original language	American English
Journal	Annals of Surgical Oncology
Volume	11
DOIs	https://doi.org/10.1007/BF02523620
State	Published - Mar 1 2004

Disciplines

Medicine and Health Sciences
Pathology

Access to Document

10.1007/BF02523620License: Unspecified

Cite this

@article{bfefe885af054cd1bfa476f2f53896f0,

title = "Clinicopathological utility of molecular staging for melanoma patients undergoing sentinel lymphadenectomy.",

author = "Hiroya Takeuchi and Bret Taback and Christine Kuo and Hoon, \{Dave S. B.\}",

note = "Lymphatic mapping and sentinel lymph node (SLN) biopsy have been validated in malignant melanoma. We hypothesized that histopathologically negative SLNs may contain occult metastases that can be...",

year = "2004",

month = mar,

day = "1",

doi = "10.1007/BF02523620",

language = "American English",

volume = "11",

journal = "Annals of Surgical Oncology",

}

TY - JOUR

T1 - Clinicopathological utility of molecular staging for melanoma patients undergoing sentinel lymphadenectomy.

AU - Takeuchi, Hiroya

AU - Taback, Bret

AU - Kuo, Christine

AU - Hoon, Dave S. B.

N1 - Lymphatic mapping and sentinel lymph node (SLN) biopsy have been validated in malignant melanoma. We hypothesized that histopathologically negative SLNs may contain occult metastases that can be...

PY - 2004/3/1

Y1 - 2004/3/1

UR - https://link.springer.com/article/10.1007/BF02523620

U2 - 10.1007/BF02523620

DO - 10.1007/BF02523620

M3 - Article

C2 - 15023743

VL - 11

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

ER -

Clinicopathological utility of molecular staging for melanoma patients undergoing sentinel lymphadenectomy.

Disciplines

Access to Document

Other files and links

Cite this